Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W Hake

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Clinical and Experimental Medicine|April 7, 2010
Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shockRanjit S Chima, Paul W Hake, Giovanna Piraino, et al.
Molecular Pharmacology|April 19, 2002
Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodentsMaeve Sheehan, Hector R Wong, Paul W Hake, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 5, 2002
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damageBasilia Zingarelli, Paul W Hake, Zequan Yang, et al.
Molecular Medicine (Cambridge, Mass.)|October 23, 2003
Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injuryBasilia Zingarelli, Paul W Hake, Michael O'Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathwaysBasilia Zingarelli, Maeve Sheehan, Paul W Hake, et al.
Shock (Augusta, Ga.)|December 19, 2018
Activation of AMP-Activated Protein Kinase by A769662 Ameliorates Sepsis-Induced Acute Lung Injury in Adult MiceLaura Kitzmiller, John R Ledford, Paul W Hake, et al.
Critical Care Medicine|October 2, 2008
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shockRanjit S Chima, Paul W Hake, Giovanna Piraino, et al.
Obesity (Silver Spring, Md.)|February 16, 2012
Short-term high fat feeding increases organ injury and mortality after polymicrobial sepsisJennifer M Kaplan, Marchele Nowell, Patrick Lahni, et al.
Shock (Augusta, Ga.)|September 16, 2017
Metformin Exerts Beneficial Effects in Hemorrhagic Shock in An AMPKα1-Independent MannerPaul Kim, Giovanna Piraino, Michael O'Connor, et al.
Molecular Medicine (Cambridge, Mass.)|October 27, 2004
Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in ratsRajesh Aneja, Paul W Hake, Timothy J Burroughs, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Clinical and Experimental Medicine|April 7, 2010
Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shockRanjit S Chima, Paul W Hake, Giovanna Piraino, et al.
Molecular Pharmacology|April 19, 2002
Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodentsMaeve Sheehan, Hector R Wong, Paul W Hake, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 5, 2002
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damageBasilia Zingarelli, Paul W Hake, Zequan Yang, et al.
Molecular Medicine (Cambridge, Mass.)|October 23, 2003
Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injuryBasilia Zingarelli, Paul W Hake, Michael O'Connor, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathwaysBasilia Zingarelli, Maeve Sheehan, Paul W Hake, et al.
Shock (Augusta, Ga.)|December 19, 2018
Activation of AMP-Activated Protein Kinase by A769662 Ameliorates Sepsis-Induced Acute Lung Injury in Adult MiceLaura Kitzmiller, John R Ledford, Paul W Hake, et al.
Critical Care Medicine|October 2, 2008
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shockRanjit S Chima, Paul W Hake, Giovanna Piraino, et al.
Obesity (Silver Spring, Md.)|February 16, 2012
Short-term high fat feeding increases organ injury and mortality after polymicrobial sepsisJennifer M Kaplan, Marchele Nowell, Patrick Lahni, et al.
Shock (Augusta, Ga.)|September 16, 2017
Metformin Exerts Beneficial Effects in Hemorrhagic Shock in An AMPKα1-Independent MannerPaul Kim, Giovanna Piraino, Michael O'Connor, et al.
Molecular Medicine (Cambridge, Mass.)|October 27, 2004
Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in ratsRajesh Aneja, Paul W Hake, Timothy J Burroughs, et al.
Pageof 4